Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare TSE:HLS CVE:RX TSE:TGOD CVE:VM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHLSHLS TherapeuticsC$4.80-1.4%C$4.81C$3.00▼C$5.23C$106.79M1.0713,424 shs17,701 shsRXBioSyentC$11.98+0.7%C$11.58C$9.20▼C$12.13C$137.02M0.934,221 shs183 shsTGODGreen Organic DutchmanC$0.00C$0.17▼C$0.65C$89.95MN/A2.66 million shs19.70 million shsVMVoyageur PharmaceuticalsC$0.26C$0.21C$0.04▼C$0.36C$39.40M0.32199,458 shs328,039 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHLSHLS Therapeutics-0.20%+1.25%-2.21%+21.14%+39.94%RXBioSyent+0.85%+1.71%-0.42%+19.00%+18.41%TGODGreen Organic Dutchman0.00%0.00%0.00%0.00%0.00%VMVoyageur Pharmaceuticals-10.34%-16.13%+33.33%+33.33%+420.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationHLSHLS TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ARXBioSyentN/AN/AN/AN/AN/AN/AN/AN/ATGODGreen Organic DutchmanN/AN/AN/AN/AN/AN/AN/AN/AVMVoyageur PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHLSHLS Therapeutics 2.00HoldC$4.50-7.60% DownsideRXBioSyent 0.00N/AN/AN/ATGODGreen Organic Dutchman 0.00N/AN/AN/AVMVoyageur Pharmaceuticals 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHLSHLS TherapeuticsC$40.13M2.70C$0.32 per share15.22C$2.51 per share1.94RXBioSyentC$34.06M4.00C$3.87 per share3.07C$3.22 per share3.69TGODGreen Organic DutchmanC$31.37M0.00N/A10.63C$0.26 per share0.00VMVoyageur PharmaceuticalsN/AN/AC$0.01 per share35.00C$0.01 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHLSHLS Therapeutics-C$15.53M-C$1.00N/A∞N/A-38.70%-25.27%-2.89%N/ARXBioSyentC$7.02MC$0.6219.31∞N/A20.60%20.01%12.86%N/ATGODGreen Organic DutchmanN/A-C$0.26N/AN/AN/AN/AN/AN/AN/AVMVoyageur Pharmaceuticals-C$1.66M-C$0.01N/A∞N/AN/A-117.77%-30.77%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthHLSHLS TherapeuticsC$0.204.11%N/AN/A N/ARXBioSyentC$0.181.51%N/A29.21%N/ATGODGreen Organic DutchmanN/AN/AN/AN/AN/AVMVoyageur PharmaceuticalsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHLSHLS Therapeutics86.501.561.01RXBioSyent2.903.926.91TGODGreen Organic Dutchman16.771.280.50VMVoyageur Pharmaceuticals4.230.100.84Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHLSHLS Therapeutics65.20%RXBioSyent1.37%TGODGreen Organic DutchmanN/AVMVoyageur PharmaceuticalsN/AInsider OwnershipCompanyInsider OwnershipHLSHLS Therapeutics0.37%RXBioSyent33.65%TGODGreen Organic DutchmanN/AVMVoyageur Pharmaceuticals10.24%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHLSHLS Therapeutics9122.25 millionN/ANot OptionableRXBioSyentN/A11.44 millionN/ANot OptionableTGODGreen Organic Dutchman41529.14 millionN/ANot OptionableVMVoyageur PharmaceuticalsN/A151.52 millionN/ANot OptionableVM, RX, HLS, and TGOD HeadlinesRecent News About These CompaniesVoyageur Pharmaceuticals (CVE:VM) Trading Down 11.5% - Here's WhyJuly 7 at 4:29 AM | americanbankingnews.comVoyageur Pharmaceuticals (CVE:VM) Shares Down 11.5% - Should You Sell?July 7 at 4:29 AM | americanbankingnews.comVoyageur Pharmaceuticals (CVE:VM) Stock Price Down 11.5% - Time to Sell?July 7 at 3:51 AM | americanbankingnews.comVoyageur Pharmaceuticals (CVE:VM) Trading Down 11.5% - Time to Sell?July 7 at 3:15 AM | americanbankingnews.comVoyageur Pharmaceuticals (CVE:VM) Stock Price Down 11.5% - Here's WhyJuly 7 at 2:35 AM | americanbankingnews.comVoyageur Pharmaceuticals (CVE:VM) Stock Price Down 11.5% - Should You Sell?July 7 at 2:49 AM | americanbankingnews.comVoyageur Pharmaceuticals (CVE:VM) Shares Down 11.5% - Here's WhyJuly 6, 2025 | americanbankingnews.comVoyageur Pharmaceuticals (CVE:VM) Stock Price Down 11.5% - What's Next?July 6, 2025 | americanbankingnews.comVoyageur Pharmaceuticals (CVE:VM) Trading Down 11.5% - Here's What HappenedJuly 6, 2025 | americanbankingnews.comVoyageur Pharmaceuticals (CVE:VM) Trading Down 11.5% - Should You Sell?July 6, 2025 | americanbankingnews.comVoyageur Pharmaceuticals (CVE:VM) Shares Down 11.5% - Here's What HappenedJuly 6, 2025 | americanbankingnews.comVoyageur Pharmaceuticals (CVE:VM) Stock Price Down 1.6% - Time to Sell?July 6, 2025 | americanbankingnews.comVoyageur Pharmaceuticals Ltd. (CVE:VM) Director Eugene Leonard Fritzel Acquires 32,250 SharesJuly 1, 2025 | insidertrades.comVoyageur Pharmaceuticals (CVE:VM) Trading 21.8% Higher - Here's WhyJune 27, 2025 | marketbeat.comVoyageur Pharmaceuticals (CVE:VM) Shares Up 20% - Here's What HappenedJune 27, 2025 | marketbeat.comVoyageur Pharmaceuticals (CVE:VM) Stock Price Up 21.8% - Should You Buy?June 27, 2025 | marketbeat.comVoyageur Pharmaceuticals (CVE:VM) Shares Up 23.6% - Time to Buy?June 27, 2025 | marketbeat.comVoyageur Pharmaceuticals (CVE:VM) Stock Price Up 20% - Should You Buy?June 27, 2025 | marketbeat.comVoyageur Pharmaceuticals (CVE:VM) Trading 12.7% Higher - Here's WhyJune 27, 2025 | marketbeat.comVoyageur Pharmaceuticals Launches First Commercial Sale of Barium Contrast AgentsJune 4, 2025 | msn.comVoyageur Launches Market Introduction of Barium Contrast Product Line Following Successful Clinical Study ResultsApril 24, 2025 | finance.yahoo.comMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir Soon3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military SpendIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBroadcom’s Big VMware Update: A Threat to Public Cloud Giants?By Leo Miller | June 28, 2025View Broadcom’s Big VMware Update: A Threat to Public Cloud Giants?VM, RX, HLS, and TGOD Company DescriptionsHLS Therapeutics TSE:HLSC$4.80 -0.07 (-1.44%) As of 01:10 PM EasternHLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company products include Clozaril, Absorica, Vascepa, CSAN Pronto, Trinomia and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States and the Rest of the world.BioSyent CVE:RXC$11.98 +0.08 (+0.67%) As of 10:23 AM EasternBioSyent Inc., together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia. It offers Tibella, a hormone replacement therapy consisting of tibolone; Inofolic, a natural health product to address polycystic ovarian syndrome symptoms; RepaGyn, a vaginal suppository for the healing of the vaginal mucosa, as well as for the treatment of vaginal dryness caused by aging, menopause, stress, and chemotherapy; and Gelclair, a gel formulated to aid the pain or oral mucositis. In addition, the company provides Cathejell, a lubricant with anesthetic with the indication of lubricating and opening the urethra before the insertion of the catheter; Combogesic to manage mild to moderate acute pain and reduction of fever in adults; and Proktis-M, a rectal suppository for the healing of the anus and rectum. The company sells its products through wholesalers and retail pharmacy chains. The company was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. in June 2006. BioSyent Inc. was founded in 2006 and is headquartered in Mississauga, Canada.Green Organic Dutchman TSE:TGODThe Green Organic Dutchman Holdings Ltd., through its subsidiaries, produces and sells organic cannabis in Canada. It offers organic cannabis products, such as cannabis plants, cannabis plant seeds, dried cannabis, fresh cannabis, cannabis oils, cannabis topicals, cannabis extracts, and edible cannabis to retailers or distributors, and federal licensed entities. The Green Organic Dutchman Holdings Ltd. was incorporated in 2016 and is headquartered in Mississauga, Canada.Voyageur Pharmaceuticals CVE:VMC$0.26 0.00 (0.00%) As of 12:57 PM EasternVoyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Will Oracle's Cloud and AI Deals Propel It to New Highs? Enovix Shares Hit 6-Month High; Long-Term Highs to Follow Tesla Stock Could Accelerate on New EV Tax Legislation SoundHound Rises as Short Sellers Exit and AI Demand Grows Why Microsoft Keeps Showing Up in Congressional Portfolios Buffett's $2B+ Bet With Big Long-Term Potential Just Got Upgraded Why Marvell Could Be the Smartest AI Bet Under $80 Autodesk Stock Ready to Rip? Q3 May Be the Turning Point Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
